Jubilant Pharmova Ltd 2025 AR2
The report highlights Jubilant Pharmova Limited's financial and operational performance for the fiscal year 2024-25, showcasing an eight percent year-on-year revenue growth to 72,345 million rupees and a twenty-four percent increase in EBITDA. The company made significant progress toward its Vision 2030, including expanding its radiopharmacy network, doubling sterile injectables capacity, and returning its Generics business to profitability. On the ESG front, the company achieved a thirty-three percent share of renewable energy in total purchased power and reduced specific greenhouse gas emissions by fifteen percent compared to its target. Additionally, its community development programs reached over two million beneficiaries through healthcare, education, and livelihood initiatives.
Company: Jubilant Pharmova Ltd
Sector: Health Care
Country: India
Year: 2025
Type: AR2
Pages: 191
Jubilant Pharmova Ltd
Annual Report
The report highlights Jubilant Pharmova Limited's financial and operational performance for the fiscal year 2024-25, showcasing an eight percent year-on-year revenue growth to 72,345 million rupees and a twenty-four percent increase in EBITDA. The company made significant progress toward its Vision 2030, including expanding its radiopharmacy network, doubling sterile injectables capacity, and returning its Generics business to profitability. On the ESG front, the company achieved a thirty-three percent share of renewable energy in total purchased power and reduced specific greenhouse gas emissions by fifteen percent compared to its target. Additionally, its community development programs reached over two million beneficiaries through healthcare, education, and livelihood initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees